10-Q Filing

NEOGENOMICS INC CIK: 1077183 Q3 2016

Filing Information

Form Type	10-Q
Accession Number	`0001564590-16-027730`
Period End Date	20160930
Filing Date	20161107
Fiscal Year	2016
Fiscal Period	Q3
XBRL Instance	neo-20160930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 79 Cash Flow Statement 59

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$11.06M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$4.76M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$37.84M	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$26.53M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$28.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.97M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$33.69M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $11,056 and $4,759, respectively)	`AccountsReceivableNetCurrent`	$48.94M	USD	Point-in-time
Accounts receivable (net of allowance for doubtful accounts of $11,056 and $4,759, respectively)	`AccountsReceivableNetCurrent`	$50.18M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	250.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	75.82M	shares	Point-in-time
Inventories	`InventoryNet`	$5.11M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	78.49M	shares	Point-in-time
Inventories	`InventoryNet`	$5.95M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	75.82M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$4.89M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	78.49M	shares	Point-in-time
Other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$7.49M	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Redeemable Convertible Preferred Stock, par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$82.36M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$92.56M	USD	Point-in-time
Property and equipment (net of accumulated depreciation of $37,840 and $26,534, respectively)	`PropertyPlantAndEquipmentNet`	$34.58M	USD	Point-in-time
Property and equipment (net of accumulated depreciation of $37,840 and $26,534, respectively)	`PropertyPlantAndEquipmentNet`	$34.17M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares authorized	`TemporaryEquitySharesAuthorized`	50.00M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$82.35M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	14.67M	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$87.80M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares issued	`TemporaryEquitySharesIssued`	14.67M	shares	Point-in-time
Goodwill	`Goodwill`	$146.18M	USD	Point-in-time
Goodwill	`Goodwill`	$146.42M	USD	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	14.67M	shares	Point-in-time
Redeemable Convertible Preferred Stock, shares outstanding	`TemporaryEquitySharesOutstanding`	14.67M	shares	Point-in-time
Goodwill	`Goodwill`	$2.93M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$174.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$129.00K	USD	Point-in-time
Total assets	`Assets`	$351.29M	USD	Point-in-time
Total assets	`Assets`	$355.43M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$13.98M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.46M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$11.38M	USD	Point-in-time
Accrued compensation	`EmployeeRelatedLiabilitiesCurrent`	$6.22M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$7.37M	USD	Point-in-time
Accrued expenses and other liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$4.38M	USD	Point-in-time
Revolving credit facility, net	`LineOfCredit`	$8.87M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$4.53M	USD	Point-in-time
Short-term portion of capital leases	`CapitalLeaseObligationsCurrent`	$5.00M	USD	Point-in-time
Short-term portion of loans	`LongTermDebtCurrent`	$600.00K	USD	Point-in-time
Short-term portion of loans	`LongTermDebtCurrent`	$646.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$35.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$40.06M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$5.51M	USD	Point-in-time
Long-term portion of capital leases	`CapitalLeaseObligationsNoncurrent`	$5.04M	USD	Point-in-time
Long-term portion of loans, net	`LongTermDebtNoncurrent`	$52.34M	USD	Point-in-time
Long-term portion of loans, net	`LongTermDebtNoncurrent`	$52.19M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilitiesNoncurrent`	$15.74M	USD	Point-in-time
Deferred income tax liability, net	`DeferredTaxLiabilitiesNoncurrent`	$16.24M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$73.12M	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$73.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$113.17M	USD	Point-in-time
Total liabilities	`Liabilities`	$109.33M	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies - see Note I	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; and 14,666,667 shares issued and outstanding, respectively)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$28.60M	USD	Point-in-time
Series A Redeemable Convertible Preferred Stock, $0.001 par value, (50,000,000 shares authorized; and 14,666,667 shares issued and outstanding, respectively)	`RedeemableNoncontrollingInterestEquityPreferredCarryingAmount`	$45.30M	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 78,494,022 and 75,820,307 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$78.00K	USD	Point-in-time
Common stock, $0.001 par value, (250,000,000 shares authorized; 78,494,022 and 75,820,307 shares issued and outstanding, respectively)	`CommonStockValueOutstanding`	$76.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$238.97M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$231.38M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-38.26M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-21.94M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$209.51M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$200.79M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$351.29M	USD	Point-in-time
Total liabilities, redeemable convertible preferred stock and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$355.43M	USD	Point-in-time

Income Statement 79 line items

Line Item	Tag	Value	Unit	Period
Clinical testing revenue	`ClinicalTestingRevenue`	$166.67M	USD	3 Qtrs
Clinical testing revenue	`ClinicalTestingRevenue`	$71.77M	USD	3 Qtrs
Clinical testing revenue	`ClinicalTestingRevenue`	$55.74M	USD	1 Quarter
Clinical testing revenue	`ClinicalTestingRevenue`	$24.88M	USD	1 Quarter
Pharma Services & research revenue	`PharmaServicesAndResearchRevenue`	$251.00K	USD	1 Quarter
Pharma Services & research revenue	`PharmaServicesAndResearchRevenue`	$16.92M	USD	3 Qtrs
Pharma Services & research revenue	`PharmaServicesAndResearchRevenue`	$5.02M	USD	1 Quarter
Pharma Services & research revenue	`PharmaServicesAndResearchRevenue`	$753.00K	USD	3 Qtrs
Total Revenue, net	`SalesRevenueServicesNet`	$72.52M	USD	3 Qtrs
Total Revenue, net	`SalesRevenueServicesNet`	$25.13M	USD	1 Quarter
Total Revenue, net	`SalesRevenueServicesNet`	$60.76M	USD	1 Quarter
Total Revenue, net	`SalesRevenueServicesNet`	$183.59M	USD	3 Qtrs
COST OF REVENUE	`CostOfServices`	$13.96M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$33.42M	USD	1 Quarter
COST OF REVENUE	`CostOfServices`	$100.47M	USD	3 Qtrs
COST OF REVENUE	`CostOfServices`	$40.99M	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$11.17M	USD	1 Quarter
GROSS MARGIN	`GrossProfit`	$31.53M	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$83.12M	USD	3 Qtrs
GROSS MARGIN	`GrossProfit`	$27.34M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$19.02M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$55.81M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$7.44M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$21.04M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$967.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$871.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.72M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.34M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$18.08M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$8.57M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$5.96M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$2.75M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$77.61M	USD	3 Qtrs
Total Operating Expenses	`OperatingExpenses`	$25.95M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$11.06M	USD	1 Quarter
Total Operating Expenses	`OperatingExpenses`	$31.95M	USD	3 Qtrs
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$-419.00K	USD	3 Qtrs
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$114.00K	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$1.40M	USD	1 Quarter
INCOME (LOSS) FROM OPERATIONS	`OperatingIncomeLoss`	$5.51M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-623.00K	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-239.00K	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNet`	$-4.51M	USD	3 Qtrs
Interest expense, net	`InterestIncomeExpenseNet`	$-1.47M	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-125.00K	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-73.00K	USD	1 Quarter
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.04M	USD	3 Qtrs
Income (loss) before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$1.00M	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-6.00K	USD	1 Quarter
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$20.00K	USD	3 Qtrs
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$500.00K	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-125.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-1.06M	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-67.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$500.00K	USD	3 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$5.52M	USD	3 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$11.18M	USD	3 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-125.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-16.20M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-5.63M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.06M	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.07	USD	1 Quarter
Basic	`EarningsPerShareBasic`	-	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$-0.02	USD	3 Qtrs
Basic	`EarningsPerShareBasic`	$-0.21	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.21	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	-	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$-0.02	USD	3 Qtrs
Diluted	`EarningsPerShareDiluted`	$-0.07	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	60.54M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	77.22M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	60.41M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	78.14M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	60.54M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	60.41M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	78.14M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	77.22M	shares	3 Qtrs

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-125.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-1.06M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-67.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$500.00K	USD	3 Qtrs
Depreciation	`Depreciation`	$4.97M	USD	3 Qtrs
Depreciation	`Depreciation`	$11.55M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$283.00K	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$93.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$5.45M	USD	3 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.80M	USD	1 Quarter
Amortization of debt issue costs	`AmortizationOfFinancingCosts`	$532.00K	USD	3 Qtrs
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensationAndWarrants`	$1.91M	USD	3 Qtrs
Stock based compensation options, restricted stock and warrants	`ShareBasedCompensationAndWarrants`	$4.02M	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$1.85M	USD	3 Qtrs
Provision for bad debts	`ProvisionForDoubtfulAccounts`	$8.18M	USD	3 Qtrs
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$9.42M	USD	3 Qtrs
(Increase) in accounts receivable, net of write-offs	`IncreaseDecreaseInAccountsReceivable`	$2.93M	USD	3 Qtrs
(Increase) in inventories	`IncreaseDecreaseInInventories`	$844.00K	USD	3 Qtrs
(Increase) in inventories	`IncreaseDecreaseInInventories`	$351.00K	USD	3 Qtrs
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$409.00K	USD	3 Qtrs
(Increase) in prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$1.48M	USD	3 Qtrs
(Increase) decrease in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$46.00K	USD	3 Qtrs
(Increase) decrease in other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-12.00K	USD	3 Qtrs
Increase in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$2.00K	USD	3 Qtrs
Increase in accounts payable and other liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$3.27M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$21.72M	USD	3 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$4.27M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$5.33M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.68M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.68M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-5.33M	USD	3 Qtrs
Repayment of revolving credit facility	`RepaymentsOfLinesOfCredit`	$10.04M	USD	3 Qtrs
Repayment of term loan	`RepaymentsOfLongTermLinesOfCredit`	$413.00K	USD	3 Qtrs
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$2.91M	USD	3 Qtrs
Repayment of capital lease obligations/loans	`RepaymentsOfLongTermDebtAndCapitalSecurities`	$3.87M	USD	3 Qtrs
Proceeds from the exercise of options, warrants and ESPP shares, net of transaction expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$599.00K	USD	3 Qtrs
Proceeds from the exercise of options, warrants and ESPP shares, net of transaction expenses	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$3.46M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-2.31M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$-10.88M	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$277.00K	USD	3 Qtrs
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$5.51M	USD	3 Qtrs
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$28.93M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$33.97M	USD	Point-in-time
Cash and cash equivalent, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$33.69M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.42M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$28.93M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$33.97M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$33.69M	USD	Point-in-time
Interest paid	`InterestPaid`	$3.99M	USD	3 Qtrs
Interest paid	`InterestPaid`	$672.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$228.00K	USD	3 Qtrs
Income taxes paid	`IncomeTaxesPaid`	$20.00K	USD	3 Qtrs
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$4.91M	USD	3 Qtrs
Equipment acquired under capital lease/loan obligations	`CapitalLeaseObligationsIncurred`	$4.38M	USD	3 Qtrs
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$1.84M	USD	1 Quarter
Deemed dividends on preferred stock	`RedeemablePreferredStockDividends`	$5.52M	USD	3 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$11.18M	USD	3 Qtrs
Amortization of preferred stock beneficial conversion feature	`AmortizationOfPreferredStockBeneficialConversionFeature`	$3.73M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.